2 Best APIs for Telemedicine in Nigeria

HealthPlus Wellness API enables integration with HealthPlus telemedicine and healthcare platform in Nigeria. The service provides access to doctor consultations, health records, and medical services. Features include appointment scheduling, prescription management, and health data storage. Ideal for Nigerian health apps and telemedicine integrations.

Infermedica Symptom Checker API is an AI-powered clinical decision support platform that provides symptom assessment, triage recommendations, and medical condition identification through a conversational API. Built by Infermedica, a medical AI company whose technology has been validated against physician diagnoses, the API powers symptom checker experiences in telemedicine apps, digital health platforms, hospital patient portals, and health chatbots that need clinically reliable medical triage logic without building medical AI from scratch. The core interaction model of the Infermedica API is a dialogue: a patient initiates a symptom assessment by describing their chief complaint, and the API responds with follow-up questions that progressively narrow the set of probable conditions. This AI-driven interview collects relevant symptoms, risk factors, and medical history data through structured yes/no and multiple-choice questions derived from probabilistic clinical reasoning models trained on millions of clinical cases. The process mimics the triage interview a clinician performs but delivers it through a digital interface that can run 24 hours a day without clinical staff involvement. The triage output from Infermedica classifies the urgency of the patient's presented symptoms into categories — emergency (call emergency services immediately), consult soon (see a doctor within 24 hours), self-care (symptoms can be managed at home) — with structured rationale for the triage classification. For Nigerian telemedicine platforms and digital health services that need to prioritize patient consultations or direct patients to appropriate care levels, the triage API provides the clinical logic layer without requiring in-house medical AI development. Condition probability output from Infermedica ranks the most likely diagnoses consistent with the symptoms and risk factors collected during the interview, with probability scores and ICD-10 codes for each condition. This differential diagnosis output helps healthcare providers who review the pre-consultation triage data focus their clinical assessment on the most likely conditions rather than starting from scratch, improving consultation efficiency. For Nigerian telemedicine platforms — where a significant proportion of consultations involve triage questions that could be handled before the doctor connects — Infermedica's symptom checker API can function as a pre-consultation digital intake tool that collects symptom history, performs initial triage, and delivers structured data to the clinician before the video call begins. This workflow improvement increases the clinical value of each consultation and reduces the amount of basic history-taking the physician must do within the consultation time. Mental health symptom assessment is supported through specific Infermedica models covering anxiety, depression, and other common mental health presentations. Nigerian mental health platforms and employee wellbeing apps can use these models to provide structured mental health screening tools that identify individuals whose symptom patterns suggest they would benefit from professional support, directing them toward appropriate services. The Infermedica API is designed for enterprise integration with developer-accessible REST API endpoints, comprehensive documentation, and sandbox environment access for testing. Nigerian health tech developers can explore the API capabilities using test credentials without production data before building health-app integrations. Regulatory compliance considerations for the Nigerian health tech context — including FMOH and NHIA guidelines — apply to how symptom checker features are presented and what clinical claims are made about the tool's outputs.